Most differentiated cells convert glucose to pyruvate in the cytosol through glycolysis, followed by pyruvate oxidation in the mitochondria. These processes are linked by the mitochondrial pyruvate carrier (MPC), which is required for efficient mitochondrial pyruvate uptake. In contrast, proliferative cells, including many cancer and stem cells, perform glycolysis robustly but limit fractional mitochondrial pyruvate oxidation. We sought to understand the role this transition from glycolysis to pyruvate oxidation plays in stem cell maintenance and differentiation. Loss of the MPC in Lgr5-EGFP-positive stem cells, or treatment of intestinal organoids with an MPC inhibitor, increases proliferation and expands the stem cell compartment. Similarly, genetic deletion of the MPC in Drosophila intestinal stem cells also increases proliferation, whereas MPC overexpression suppresses stem cell proliferation. These data demonstrate that limiting mitochondrial pyruvate metabolism is necessary and sufficient to maintain the proliferation of intestinal stem cells.
It was first observed almost 100 years ago that, unlike differentiated cells, cancer cells tend to avidly consume glucose, but not fully oxidize the pyruvate that is generated from glycolysis 1 . This was originally proposed to be due to dysfunctional or absent mitochondria, but it has become increasingly clear that mitochondria remain functional and critical. Mitochondria are particularly important in proliferating cells because essential steps in the biosynthesis of amino acids, nucleotide and lipid occur therein [2] [3] [4] [5] . Most proliferating stem cell populations also exhibit a similar glycolytic metabolic program [6] [7] [8] [9] , which transitions to a program of mitochondrial carbohydrate oxidation during differentiation 10, 11 . The first distinct step in carbohydrate oxidation is import of pyruvate into the mitochondrial matrix, where it gains access to the pyruvate dehydrogenase complex (PDH) and enters the tricarboxylic acid (TCA) cycle as acetyl-CoA. We, and others, recently discovered the two proteins that assemble to form the mitochondrial pyruvate carrier (MPC) 12, 13 . This complex is necessary and sufficient for mitochondrial pyruvate import in yeast, flies and mammals, and thereby serves as the junction between cytoplasmic glycolysis and mitochondrial oxidative phosphorylation. We previously showed that decreased expression and activity of the MPC underlies the glycolytic program in colon cancer cells in vitro and that forced re-expression of the MPC subunits increased carbohydrate oxidation and impaired the ability of these cells to form colonies in vitro and tumours in vivo 14 . This impairment of tumorigenicity was coincident with a loss of key markers and phenotypes associated with stem cells. This prompted us to examine whether glycolytic non-transformed stem cells might also exhibit low MPC expression and mitochondrial pyruvate oxidation, which must increase during differentiation.
RESULTS

MPC expression is low in intestinal stem cells and increases following differentiation
As a model system, we have studied LGR5 + intestinal stem cells (ISCs), which reside near the base of the intestinal crypt and continuously proliferate. Their progeny differentiate and populate the intestinal epithelium, which is completely renewed approximately every 5 days 15, 16 . Using EGFP fluorescence from an Lgr5-EGFP-IRES-CreERT2 allele, we single-cell-sorted intestinal crypt stem cells into low-, medium-and high-LGR5-expressing populations (Supplementary Fig. 1a ). As expected Lgr5 messenger RNA, as well as that of other markers of stem cells, correlated with Lgr5-EGFP expression, while Krt20 and other markers of differentiation anti-correlated with EGFP ( Fig. 1a,b and Supplementary Table 1 ). The pattern of Mpc1 and Mpc2 expression resembled that of differentiation genes, exhibiting lower expression in the more stem-like cells that increased with differentiation. In vitro organoids maintained in stem cell or differentiationpromoting conditions displayed a similar pattern. When grown in basal medium containing EGF and Noggin, organoids exhibit a largely differentiated gene expression pattern, which is progressively more stem-like when R-spondin 1 and Wnt3a are added to the medium (Fig. 1c,d and Supplementary Table 2 ). Expression of Mpc1 and, to a lesser extent, Mpc2 again correlate with the expression of differentiation genes. Both in vivo and in vitro, the expression of indicators of mitochondrial biogenesis such as Tfam and Nrf1 was higher in more stem-like cell populations ( Fig. 1a-d ) suggesting that the decreased MPC expression is not due to a global suppression of mitochondrial gene expression. Similarly, immunohistochemical analysis of the proximal small intestine (jejunum) revealed that MPC1 was nearly absent from the base of the crypt, the site of LGR5 + ISCs, but strongly expressed through the upper crypt and villus, whereas VDAC, a marker of total mitochondrial mass, was more abundant at the base of the crypt relative to the remainder of the intestinal epithelium in both mouse and human (Fig. 1e ). Similar anti-correlation of MPC1 and LGR5 expression was observed by immunofluorescence staining of small intestine (Fig. 1f ). This pattern of MPC1 and VDAC expression was consistent throughout the murine small intestine (jejunum and ileum) and NRF1, TFAM and PDK1 were also more abundant in the crypt cells in human intestine while the differentiation mark CK20 was less abundant 17, 18 (Supplementary Fig. 1b,c ). Electron microscopy also showed high mitochondrial content in crypt stem cells, and isolated Lgr5-EGFP stem cells robustly stain with a dye dependent on mitochondrial membrane potential ( Fig. 1g ,h). These data are consistent with the hypothesis that crypt stem cells contain functional mitochondrial, but that they are geared toward biosynthetic activities or oxidation of fatty acids or other non-carbohydrate fuels.
Drosophila MPC regulates intestinal stem cell proliferation
These observations led us to hypothesize that the MPC plays an active and direct role in regulating ISC proliferation. To begin to test this hypothesis, we examined the role of the MPC in the ISCs of the fruit fly Drosophila, which share key aspects of their biology with mammalian ISCs 19, 20 . Both MPC1 and MPC2 are expressed in all four cell types of the intestine, with the lowest level of expression in the ISCs and the highest expression in the differentiated enteroendocrine cells 21, 22 . Confocal imaging of intestines dissected from dMPC1 mutants revealed that the epithelium exhibits multilayering unlike the normal single-cell layer seen in controls ( Fig. 2a ). This is a classic overgrowth phenotype that is associated with oncogene mutations in Drosophila 20 . Accordingly, we used MARCM clonal analysis to determine whether a specific loss of the MPC in ISCs leads to an increase in their proliferation 23 . On average, newly divided GFP-marked dMPC1 mutant clones are more than twofold larger than control clones, which were generated in parallel using a wild-type chromosome, indicating that the MPC is required in the ISC lineage to suppress proliferation ( Fig. 2b and Supplementary Table 7 ). Because GFP-marked clones could include cells that differentiate into mature enterocytes or enteroendocrine cells, we also conducted clonal analysis in the absence of Notch, thereby blocking ISC differentiation 24, 25 . Under these conditions, we again observed an approximately twofold increase in the size of dMPC1 mutant ISC clones ( Fig. 2c and Supplementary Table 7 ). To confirm and extend these results, we disrupted MPC function specifically in the ISCs by using the Dl-GAL4 driver in combination with UAS-GFP, which facilitates stem cell identification. Once again, approximately twofold more GFP-marked stem cells were observed relative to controls when either dMPC1 or dMPC2 expression was disrupted by RNA-mediated interference (RNAi) along with increased ISC proliferation as detected by staining for phosphorylated histone H3 (pHH3) ( Fig. 2d ). Similar results were obtained when RNAi was targeted to the E1 or E2 subunits of PDH to specifically disrupt the next step in mitochondrial pyruvate oxidation ( Fig. 2d and Supplementary Fig. 2a and Supplementary  Table 7 ). Importantly, an opposite phenotype was seen when Ldh was reduced by RNAi in the ISCs or progenitor cells ( Fig. 2e ,f and Supplementary Fig. 2a and Supplementary Table 7 ). Ldh suppression is known to result in a significant increase in pyruvate levels, which can promote pyruvate oxidation 26 . Taken together with our results with Pdh RNAi, these observations support the model that the MPC limits stem cell proliferation through promoting oxidative pyruvate metabolism in the mitochondria. It also appears to be sufficient as specific overexpression of MPC1 and MPC2 in ISCs or progenitors caused a reduction in stem cell proliferation, the opposite of the loss-of-function phenotype. This can be seen in either Pseudomonasinfected intestines ( Fig. 2e and Supplementary Fig. 2a ), which undergo rapid stem cell proliferation 27 , or under basal conditions in aged animals ( Fig. 2f ). Consistent with this, MPC overexpression under basal conditions had no effects on intestinal morphology, while the intestines from infected flies displayed a fully penetrant size reduction, which is probably due to the inability of ISCs to maintain tissue homeostasis ( Fig. 2g and Supplementary Figs 2b and 7c ). Taken together, our results demonstrate that mitochondrial pyruvate uptake and metabolism is both necessary and sufficient in a stem cell autonomous manner to regulate ISC proliferation and maintain intestinal homeostasis in Drosophila.
MPC deletion in the Lgr5-EGFP cells expands the intestinal stem cells compartment and increases proliferation
To test whether loss of the mammalian MPC might have similar effects on ISC homeostasis, we generated mice carrying the Lgr5-EGFP-IRES-CreERT2 allele together with homozygous floxed alleles of Mpc1 ( Supplementary Fig. 3a ). Tamoxifen treatment resulted in a significant but incomplete (∼30%) loss of MPC1 in the proximal small intestine at 30 days ( Fig. 3a,f ). Loss of MPC1 had no effect on body weight and caused no change in the morphology or height of intestinal crypts or villi ( Fig. 3a and Supplementary Figs 3b-d ).
We also observed no change in alcian blue staining, which marks goblet cells or perturbation in the mature enterocyte marker CK20 ( Fig. 3a and Supplementary Fig. 3e ). These animals exhibited, however, a significant increase in the number and zone size of actively proliferating cells in the crypt as measured both by BrdU incorporation and Ki67 staining (Fig. 3b,c and Supplementary Fig. 3f ).
In addition, Mpc1 Lgr5-KO mice had an increased number of crypt stem cells as assessed by Olfm4, Lgr5 and LRIG1 expression as well as by expression of GFP from the Lgr5-EGFP allele (Fig. 3d,e and Supplementary Fig. 3g -i). Consistent with these data, we found that the zone of MPC1-deficiency increased over time post-Mpc1 deletion, suggesting positive selection for Mpc1-deleted cells (Fig. 3f ). These data support our results in Drosophila and demonstrate that Mpc1 Lgr5-KO crypts display increased cell cycling and ISC expansion. In vitro loss of the MPC increases stem cell function and organoid formation A dramatic increase in organoid-forming potential was observed after plating crypts isolated from Mpc1 Lgr5-KO mice, supporting the conclusion that these animals have an enlarged population of proliferating ISCs ( Fig. 4a and Supplementary Table 7 ). Similar results were seen when organoids were established from single Lgr5 + stem cells treated with tamoxifen in vitro to eliminate MPC1 ( Fig. 4b and Supplementary Table 7 ), exhibiting more Lgr5-EGFPpositive branches (Fig. 4c ). When cells from these organoids were dissociated and sorted, Mpc1 Lgr5-KO organoids maintained a higher fraction of GFP-positive cells ( Fig. 4d and Supplementary Fig. 4a and Supplementary Table 7 ). When cells from these wild-type and Mpc1 Lgr5-KO organoids were dissociated, but not sorted for EGFP, those from Mpc1 Lgr5-KO organoids maintained their increased organoidforming ability ( Fig. 4e ) and were more likely to be Lgr5-EGFP-positive ( Fig. 4f ). This increase in organoid formation of single Mpc1 Lgr5-KO cells was maintained over extended passaging over two months ( Supplementary Fig. 4b ). Moreover, Mpc1 Lgr5-KO organoids transferred to basal medium lacking the drugs that maintain stemness rapidly lost EGFP fluorescence, while Mpc1 Lgr5-KO organoids retained significant EGFP expression surrounding the autofluorescent lumen ( Fig. 4g ).
In vitro loss of the MPC alters protein expression and metabolism
To further define the molecular effects of MPC loss, we isolated wild-type and Mpc1 Lgr5-KO organoid populations and subjected them to protein analysis. As expected, Mpc1-deleted organoids had an essentially complete loss of MPC1 protein, and a significant reduction in MPC2, which is dependent on MPC1 for its stability ( Fig. 5a and Supplementary Figs 4c and 7a,d) 14, [28] [29] [30] . Both the LGR5 and betacatenin stem cell markers were elevated in Mpc1 Lgr5-KO organoids ( Fig. 5a and Supplementary Fig. 7 ), consistent with effects on the mRNAs encoding stem and differentiation marks (Supplementary Fig. 4d and Supplementary Table 3 ). We also observed that histone acetylation, and specifically H3K27 and H3K4 acetylation marks, were decreased in Mpc1-deleted organoids ( Fig. 5b and Supplementary  Figs 4e and 7b ). As expected, Mpc1 Lgr5-KO organoids exhibited a steadystate increase in pyruvate and a decrease in citrate, malate and alphaketoglutarate, consistent with a failure of cytoplasmic pyruvate to enter the mitochondrial TCA cycle ( Fig. 5c and Supplementary Fig. 4f ). Mpc1 Lgr5-KO organoids also showed a significant impairment in flux of 13 C-glucose into the TCA cycle as measured by M+0 loss and M+2 accrual in the citrate pool ( Fig. 5d and Supplementary Table 7 ). Oxygen consumption was also markedly impaired under both basal and FCCP-stimulated (maximal) conditions in both Mpc1 Lgr5-KO organoids and wild-type organoids treated with UK-5099, which is a specific and efficacious MPC inhibitor 12, 13, 31 (Fig. 5e ). No further decrease in oxygen consumption was observed when Mpc1 Lgr5-KO organoids were treated with the inhibitor. This led us to explore whether fatty acid oxidation might be increased to compensate for loss of Mpc1-dependent carbohydrate oxidation. In fact, we found that etomoxir-sensitive respiration (that is, fatty acid oxidation) was profoundly increased by either inhibition or genetic deletion of MPC function (Fig. 5f ).
In vitro inhibition of MPC activity increases organoid formation
In addition to genetically MPC-deficient organoids, we next utilized the MPC inhibitor UK-5099 to examine the effects of acute MPC loss. Similar to Mpc1 Lgr5-KO organoids, we found that treatment of cryptderived organoids with UK-5099 led to enhanced maintenance of EGFP expression in the epithelial lining ( Fig. 6a ) and a larger number of crypt-like branches per organoid, indicative of increased stem cell activity ( Fig. 6b and Supplementary Table 7 ). We also observed that UK-5099 treatment caused an approximately fourfold increase in the efficiency of organoid formation from proximal small intestine ( Fig. 6c and Supplementary Table 7 ). When treated organoids were dissociated and assessed by flow, UK-5099 treatment significantly increased the percentage of GFP-positive cells ( Fig. 6d and Supplementary Table 7 ). MPC inhibition enhanced organoid formation from all regions of the small intestine and from the colon to a degree similar to that of the canonical organoid-maintaining condition containing valproic acid and CHIR99021 ( Supplementary Fig. 5a ). We also observed that human colon organoid colony formation and growth was promoted by UK-5099 treatment ( Fig. 6e and Supplementary Table 7 ). Interestingly, organoids could be maintained for at least one year of continuous UK-5099 treatment and they continued to display an increase in crypt domains per organoid (Fig. 6f ). The addition of UK-5099 also improved passaging efficiency of early crypts ( Supplementary Fig. 5b ). When organoids were transferred to differentiation conditions, treatment with UK-5099 resulted in maintenance of Lgr5-EGFP expression in the crypt domains ( Fig. 6g) . Similarly, when removing stem-cell-maintaining factors and allowing passive differentiation, UK-5099 delayed the emergence of highly autofluorescent organoid lumens, suggesting fewer or lower activity of differentiated secretory cells ( Supplementary Fig. 5c ). We also examined the effect of MPC inhibition in comparison and combination with the HDAC inhibitor valproic acid and/or the GSK-3beta inhibitor CHIR99021, both of which promote stem cell maintenance independent of the Paneth cell niche 32 . UK-5099 and valproic acid caused a similar increase in organoid formation from crypts relative to controls, and resulted in a similar additive effect when combined with CHIR99021 ( Fig. 6h and Supplementary  Table 7 ) with each drug being used at its optimal concentration ( Supplementary Fig. 5d ). The GSK-3beta inhibitor had stronger effects than either of the other two drugs alone and was also additive with all other combinations. We conclude that MPC inhibition has profound effects on stem cell maintenance that are at least partially mechanistically distinct from those caused by HDAC or Organoid number * NS * * * * * * * * * * * * * * * GSK-3beta inhibition. Given the previous suggestion that valproic acid might inhibit the MPC 33,34 , we examined 13 C-glucose flux with and without valproic acid and found that valproic acid had no effect on the kinetics of citrate labelling, demonstrating that, at the concentrations used, this drug does not inhibit MPC activity ( Supplementary Fig. 6a ).
These observations of enhanced stem cell function and previously described metabolic effects (Fig. 5d-f ) of UK-5099 treatment were accompanied by changes in the expression of molecular markers of stemness. UK-5099 treatment in mixed organoid populations led to a robust increase in several stem cell markers, including Lgr5, Ascl2, Cd44 and Myc, along with a substantial decrease in the abundance of the Krt20, Villin1, Chga and Fabp2 differentiation markers (Fig. 6i,j and Supplementary Table 4 ). These data demonstrate that loss of mitochondrial pyruvate import leads to enhanced maintenance of molecular and functional markers of ISCs (and decreased markers of differentiation) to a degree similar to well-described stem-cellmaintaining agents.
Finally, we performed the converse of prior experiments and tested the hypothesis that forced expression of Mpc1 and Mpc2 in LGR5 + ISCs causes a loss of stemness. Indeed, using a previously validated system for overexpression 14 , we found that those cells expressing exogenous Mpc1 and Mpc2, which are both required for MPC function, were much less likely to maintain Lgr5 expression, as indicated by EGFP fluorescence (Fig. 6k and Supplementary Fig. 6b and Supplementary  Table 7 ). This is consistent with work suggesting that stimulating glucose oxidation with the small molecule dichloroacetate (DCA) or by substitution of glucose with galactose promotes differentiation 10 .
DISCUSSION
Our studies in Drosophila, intestinal organoids and mice provide strong evidence that the MPC is necessary and sufficient in a cell autonomous manner to suppress stem cell proliferation. Consistent with this, we have demonstrated that ISCs maintain low expression of the subunits that comprise the MPC, which enforces a mode of carbohydrate metabolism wherein glucose is metabolized in the cytosol to pyruvate and other biosynthetic intermediates. This glycolytic metabolic program appears to be sufficient to drive robust and continuous stem cell proliferation 35 . We also observed high mitochondrial content in ISCs, which must be geared primarily toward biosynthetic functions and/or oxidation of other substrates such as fatty acids. Increased fatty acids, the metabolism of which is enhanced in MPC-deficient and MPC-inhibited organoids, have been shown to promote ISC expansion and proliferation via enhanced betacatenin signalling and increasing tumour-initiating capacity 36 . MPC expression increases following differentiation, consistent with the shift in demand from macromolecule biosynthesis to ATP production in support of post-mitotic differentiated cell function. A similar switch in MPC expression can be seen following differentiation of embryonic stem cells, haematopoietic stem cells and trophoblast stem cells [37] [38] [39] [40] [41] . Conversely, MPC expression is reduced after reprogramming fibroblasts to induced pluripotent stem cells [42] [43] [44] [45] . This suggests that the effects of altering pyruvate flux that we observe herein might not be restricted to ISCs, but instead be representative of similar effects on multiple stem cell populations (see also the accompanying manuscript on hair follicle stem cells 46 ). Interestingly, Myc is known to drive a metabolic program that is similar to that observed following MPC loss, characterized by increased glycolysis and reliance on glutamine and fatty acid oxidation with reduced glucose oxidation [47] [48] [49] . This suggests that Myc may play a role in repressing the MPC in stem cells, possibly acting downstream of Wnt/beta-catenin signalling 50 . Consistent with this, Myc and its repressive co-factors localize to the Mpc1 promoter and Myc expression is strongly anti-correlated with Mpc1 expression ( Supplementary Fig. 6c ) 14,51-54 .
Taken together, our studies demonstrate that changes in the MPC and mitochondrial pyruvate metabolism are required to properly orchestrate the proliferation and homeostasis of intestinal stem cells. Importantly, this metabolic program-mediated at least partially by the MPC-appears to be instructive for, rather than a downstream consequence of, cell fate. Future work will define the extent to which the results presented herein relate to those showing that diet quality and quantity can modulate ISC behaviour. It is tempting to speculate that ISC metabolism is used as a signal for increased or decreased demand for intestinal epithelium. Perhaps of most importance will be to define the mechanisms whereby altered partitioning of pyruvate metabolism affects stem cell proliferation and fate. We speculate that the robust changes that we observed in fatty acid oxidation and histone acetylation, which are probably downstream of altered metabolite utilization for acetyl-CoA production, play an important role 36, [55] [56] [57] . While the mechanisms are not as yet defined, these studies establish a paradigm wherein mitochondrial metabolism does not merely provide a permissive context for proliferation or differentiation, but rather plays a direct and instructive role in controlling stem cell fate.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper METHODS Mice. Heterozygous Lgr5-EGFP-IRES-CreERT2 mice were obtained from Jackson Labs 58 . MPC1 fl/fl mice were generated as previously described 59 . Control animals consisted of Lgr5-EGFP-IRES-CreERT2 × MPC1 WT/WT or MPC1 fl/fl mice negative for Lgr5-EGFP-IRES-CreERT2. For in vivo knockout 6-to 8-week-old mice were injected intraperitoneally with 100 µl of 20 mg ml −1 tamoxifen (Sigma Aldrich T5648) dissolved in peanut oil (Sigma Aldrich P2144) for three successive days and euthanized 8, 30 or 160 days later. BrdU (Invitrogen b23151) was dissolved in PBS to 10 mg ml −1 and 100 µl was injected intraperitoneally 4 h before euthanization to label dividing cells. Injections were carried out in the morning (between 7:00 and 11:00) and tissue was collected 4 h later ±10 min from the time of injection. A 2 cm section was used for crypt dissociation and organoid formation as described below. The remainder of the small intestine was divided and fixed in buffered 10% formalin (Fisher Scientific 23-245-685) as previously described 60 for 48 h, transferred to 70% ethanol and paraffin-embedded for sectioning and staining. No formal randomization was performed for animal studies, animals were used as they became available, paired with littermate controls where possible, there was no preference for male or female animals, and both genders were included in each analysis. All IACUC guidelines were followed and the protocol for animal experiments carried out in this study was submitted to the University of Utah Institutional Animal Care and Use Committee.
Drosophila stocks. Drosophila stocks were maintained on standard food containing 3% sucrose, 6% glucose, 8% yeast and 1% agar in a 25 • C incubator. For dMPC1 genetic studies, control flies were homozygous for a precise excision of the P(XP)CG14290[d00809] P-element insertion, and mutant flies were transheterozygous for the two deletion alleles, dMPC1 1 and dMPC1 2 , as described previously 12 . Dl-GAL4 (a gift from B. Edgar) was used to target RNAi to the ISCs and esg-GAL4 (a gift from B. Edgar) was used to target RNAi to the ISCs and enteroblasts. RNAi transgenic stocks are as follows: UAS-dMPC1 RNAi and UAS-dMPC2-RNAi 12 , UAS-PDH-E1 (VDRC101856), UAS-PDH-E2 (VDRC 102893) and UAS-Notch-RNAi (a gift from C. Micchelli). Temperature-sensitive Tub-GAL80ts was utilized to restrict RNAi to adults. For temperature-shift experiments, animals were raised at 18 • C and 4-5-day-old adults were transferred to 29 • C for five days after which intestines were dissected for analysis. Pseudomonas infections were performed as described previously 27 . The Pseudomonas strain was a gift from B. Edgar. Overexpression of the MPC was achieved by inserting the open reading frames for dMPC1 and dMPC2 downstream from the UAS promoter in the pUAST-attB vector, with the coding sequence for the P2A peptide joining the two MPC coding regions 61 . This was inserted into the attP40 site on the second chromosome using standard methods, and expression was achieved using GAL4 drivers specific to the ISCs or progenitor cells. All Drosophila studies were performed following standard ethical guidelines for working with this organism. As is standard in studies of Drosophila intestinal stem cells, all experiments were performed in females, which have a higher rate of basal stem cell proliferation than males. Experiments were conducted in adults aged four days to three weeks after eclosion.
Mosaic analysis. The MARCM system was used to generate wild-type and dMPC1 mutant lineages as previously described 23 . Four-to five-day-old adult female flies of the following genotypes were subjected to two 38 • C heat pulses for 30-40 min: y, w, hs-FLP, UAS-GFP / w ; +; Tub-GAL4, FRT82B, Tub-Gal80 / FRT82B (control), y, w, hs-FLP, UAS-GFP / w ; +; Tub-GAL4, FRT82B, Tub-Gal80 / FRT82B dMPC1 1 (mutant). Clones were analysed three weeks after induction. The number of nuclei in GFP-expressing clones was used for quantification. For the dMPC1 MARCM studies in the presence of Notch RNAi, intestines were analysed five days after clone induction. Intestines were stained with antibodies to detect GFP and Prospero, with DAPI to mark nuclei. Animals of the following genotype were used: y, w, hs-FLP, UAS-GFP / w ; UAS-Notch-RNAi ; Tub-GAL4, FRT82B, Tub-GAL80 / FRT82B (control, Notch RNAi only), y, w, hs-FLP,UAS-GFP / w; UAS-Notch-RNAi; Tub-GAL4, FRT82B, Tub-GAL80 / FRT82B dMPC1 1 (Notch RNAi and dMPC1 mutant clones). Only clones that were negative for enteroendocrine cells (Prospero negative) and enterocytes (larger nuclei) were included in the analysis.
Histology and immunostaining. Adult flies were dissected in 1×PBS and the gastrointestinal tract was fixed in 4% formaldehyde (Polysciences, EM grade) overnight at 4 • C. Tissues were washed four times with 0.1% Triton, 1×PBS (PBST) and incubated with PBST and primary antibodies overnight, washed again, and then incubated for 3-4 h with secondary antibodies in PBST. Samples were mounted using Vectashield (Vector) with DAPI. Antibody information is provided in Supplementary Table 5 . Images were acquired using an Olympus FV1000 confocal microscope and assembled into Z stack projections for the figures. For the RNAi experiments, GFP-positive cells were quantified per ×40 frame in the mid-R2 region of the intestine. For the number of dividing cells, the average number of PHH3positive cells for the entire midgut was reported.
Crypt and single-cell isolation. Small intestinal crypts and single GFP-positive cells were isolated as previously described 15 . The entire small intestine was harvested, opened longitudinally and washed with PBS. Mucus and villi were scraped and discarded using a thin glass coverslip and tissue was cut into small (approximately 2 cm) sections. These were washed again in PBS and incubated in 2.5 mM EDTA diluted in PBS for 1 h with gentle agitation at 4 • C. Crypts were liberated and collected by centrifugation (400g for 5 min at 4 • C) followed by washing with PBS to remove EDTA. Crypts in PBS were passed through a 70-µm cell strainer and centrifuged as before. This pellet was resuspended in 50% culture medium (described below) and 50% Corning Growth Factor-Reduced Matrigel (Fisher Scientific no. 356231) for culture or dissociated for single cells. Single-cell isolation was carried out as described previously 62 by resuspending crypts in TrypLE Express (Invitrogen no. 1260413) with DNase I (Gold Biotechnology no. D-300-1) for 10 min at 37 • C. Dissociated cells were washed in culture medium without growth factors, centrifuged at 700g , resuspended and passed through a 35-µm strainer (Fisher Scientific no. 08-771-23) and analysed by FACS. Negative staining was carried out with DAPI and single live cells were collected, pelleted and snap-frozen for analysis or resuspended for culture.
Culture of crypts and single cells.
Crypts or single cells were maintained as previously described 15 with minimal modification. For regional specific assays of organoid formation the intestine was divided up as follows: the duodenum was classified as the first 4-5 cm, jejunum was classified as the proximal half, and ileum the distal half. The entire colon, excluding the caecum and rectum were pooled and crypts isolated. Medium consisted of advanced DMEM/F12 (Invitrogen no. 12634028) medium prepared with HEPES (Invitrogen no. 15630-080), Glutamax (Invitrogen no. 35050061), and Penicillin-Streptomycin (Invitrogen no. 15140122) with N-2 supplement (Invitrogen no. 17502048), B27 serum-free supplement (Invitrogen no. 17504044) N -acetyl-L-cysteine (1 mM) containing all growth factors (Wnt3A to final concentration 2.5 ng ml −1 : Peprotech no. 315-20, Noggin to final concentration 100 ng ml −1 : Peprotech no. 250-38, EGF to final concentration 50 ng ml −1 : Gold Biotechnology no. 1350-04-500, mRSPO1-Fcconditioned medium from 293T cells provided by C. Kuo at Stanford University, USA, as previously described 63 ) and 50% Matrigel (Fisher Scientific no. 356321). Crypts were resuspended in medium and Matrigel was spotted in the centre of wells in a 48-well plate and allowed to polymerize at 37 • C prior to overlaying with medium. Inhibitors CHIR99021 (3 µM, R & D Systems no. 4423), valproic acid (1 mM made fresh each day, R & D Systems no. 28-151-100) and UK-5099 (10 µM, R & D Systems no. 4186) used to compare organoid formation from crypts were added to the crypt Matrigel mixture as well as to the medium overlay and changed every 2-3 days. These drug concentrations were identified as standard from previous studies (CHIR99021: 3 µM, valproic Acid: 1 mM, and UK-5099 10 µM) but were titrated for efficacy at dosages of 0.5×, 1.0×, 3.0× and 9.0×. Total organoid number and number of crypt domains per organoid were counted after 9 days. For single cells, CHIR99021 and valproic acid were added to maintain Lgr5 stem cells as previously described 32 along with Rho kinase inhibitor Y-27613 (10 µM Fisher Scientific no. 125410), Jagged-1 (1 µM AnaSpec, Inc no. AS-61298).
Organoid knockout. Single Lgr5-EGFP-positive cells from MPC1 fl/fl × Lgr5-EGFP-IRES-CreERT2 were sorted and plated as above. Control genetically matched samples received dimethylsulfoxide and genetic recombination was induced using (Z)-4-hydroxytamoxifen (200 nM, Fisher Scientific no. . Organoids grown from these were re-sorted for live EGFP-positive cells and plated as above or collected for mRNA analysis. Prior to use of knockout organoid culture in further experiments, loss of MPC1 was verified by western blot where we also looked for a significant destabilization of MPC2. If we could still detect MPC1 protein, cultures were retreated with (Z)-4-hydroxytamoxifen and purified by flow cytometry. In addition, we routinely assessed MPC1 when blotting for other targets to ensure the knockout was stable and no wild-type escaper cells repopulated the culture.
Secondary organoids.
Organoids were passaged to single cells as above. Cell viability was determined by exclusion of 0.2% trypan blue (Sigma Aldrich) and both cell number and viability counted using the Cellometer Auto T4 (Nexcelom). Organoid formation and percentage of EGFP positivity from single live cells was measured once mature organoids had formed (7-9 days).
Organoid differentiation. Organoids grown for differentiation were passaged to single cells and allowed to establish for 6-8 days in standard medium. Following this, medium was replaced with medium lacking Wnt3A and RSPO1-conditioned medium (EN) lacking Wnt3A (ENR), or medium supplemented with 90 ng ml −1 Wnt3A (ENR +Wnt). Organoids were maintained in this medium for 48 h with fresh medium added after 24 h. To promote robust differentiation, IWP-2 (2 µM Fisher Scientific no. 35-331-0) and DAPT (10 µM Fisher Scientific no. 26-341-0) were added to organoid medium along with vehicle (dimethylsulfoxide) or UK-5099 the NE-PER Nuclear and Cytoplasmic Extraction Kit (ThermoFisher cat. no. 78835) and following all instructions. Samples were resolved by SDS-PAGE, and analysed by immunoblotting for organoid experiments and Tris-Tricine Gel for Drosophila experiments. Primary antibodies were obtained from Abcam or Cell Signaling Technology: Supplementary Table 5 . Corresponding secondary antibodies (rabbit: 680 and mouse: 800 channel) were visualized using the Odyssey scanner (Li-Cor).
Steady-state metabolomics. For steady-state metabolite accumulation, control and knockout organoids were passaged to single cells and replated in basal medium without drug (wENR). These organoids were grown for 8 days with medium changes every 2-3 days and approximately 12 h prior to harvest medium was refreshed. For harvest, organoids in Matrigel were mechanically disrupted and dissolved using ice-cold 0.9% sodium chloride, spun to 5,000g for 30 s, supernatant aspirated and samples snap-frozen with liquid nitrogen. Metabolites were extracted as previously described 12 . Briefly 450 µl of cold 90% methanol solution with internal standards (1 µg of d4-succinic acid) was added to each sample, vortexed briefly and sonicated for 3 min. This was kept at −20 • C for 1 h, centrifuged at 20,000g for 5 min at 4 • C, and the supernatant transferred to a new tube, and sample was dried in a speed-vac. All GC-MS analysis was performed with a Waters GCT Premier mass spectrometer fitted with an Agilent 6890 gas chromatograph and a Gerstel MPS2 autosampler. Dried samples were suspended in 40 µl of 40 mg ml −1 O-methoxylamine hydrochloride (MOX) in pyridine and incubated for one hour at 30 • C. Metabolites were identified and their peak area was recorded using QuanLynx. These data were transferred to an Excel spread sheet (Microsoft). Metabolite identity was established using a combination of an in-house metabolite library developed using pure purchased standards and the commercially available NIST library.
Flux metabolic labelling and cell lines. Organoids were passaged and grown as above. Multiple (∼30) 5 µl organoid Matrigel spots were plated into wells of a 6well plate, overlaid with medium, and allowed to establish for approximately 1 week. Sixteen hours before beginning flux labelling, medium was changed to minimal medium (wENR as above) with and without UK-5099 (10 µM). At time 0, sample was taken for reference and medium was removed, organoid plates washed gently with warm PBS and changed to flux medium consisting of SILAC Advanced DMEM/F12 (ThermoFisher no. A2494301) with 10 mM U-13 C 6 -glucose (CLM-1396-10), growth factors and supplements as above but lacking glutamine, unlabelled glucose, or amino acids. Flux labelling of cell lines was carried out as above in DMEM lacking any carbon source (Invitrogen 11966025) supplemented with 10 mM U-13 C 6 -glucose (CLM-1396-10), Glutamax (Invitrogen no. 35050061), and 10% fetal calf serum. For drug treatment, 10 µM UK-5099 and 1 mM valproic acid were added to the above medium. C2C12 cells were purchased from ATCC (CRL-1772) and tMEFs were a gift from D. Tantin (University of Utah, USA). No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated and were not tested for mycoplasma contamination.
Electron microscopy. Tissue was saved for electron microscopy by cutting approximately 1 mm doughnuts and fixed overnight at 4 • C in fresh 2.5% glutaraldehyde (Electron Microscopy Sciences no. 16320) diluted in PBS. The next day tissue was washed three times in cacodylate buffer. Secondary fixation was carried out in 2% osmium tetroxide at room temperature for 1 h followed by two washes with cacodylate buffer followed by one wash with water. Staining used saturated uranyl acetate for 1 h at room temperature, washed three times with water, and dehydrated with a graded ethanol series (30%, 50%, 70%, 95% ×2, 100% ×3, and finally absolute acetone). Infiltration was carried out with Epon epoxy resin (30% for 5 h, 70% overnight, 100% for 8 h with three changes) and tissue was embedded with 100% fresh resin. Polymerization in fresh resin was carried out at 60 • C for 48 h followed by ultracutting (Leica UC6 ultratome) at 70 nm. Images were collected using a JEM-1400 Plus Transmission Electron Microscope (JEOL).
Seahorse. Control and MPC1 knockout organoids for oxygen consumption studies were passaged by mechanical disruption rather than complete dissociation to single cells. Organoid fragments were spotted into a 6-well dish with multiple <10 µl spots per well and overlaid with 2 ml of organoid growth medium. Two days following plating, the medium was changed with the addition of vehicle or 10 µM UK-5099. For assay, seahorse analysis, organoids were extracted from Matrigel with gentle pipetting to minimize disaggregation. An XF96 well plate was coated with a 1:10 dilution of Matrigel in PBS and allowed to sit at room temperature for 1 h. Organoids were evenly seeded in each well with the respective medium (wENR CV ± UK-5099). The following day, organoids were run on an XF96e Analyzer for a Mito Stress Test in standard assay medium (DMEM, 25 mM glucose, 2 mM pyruvate, 2 mM glutamine, pH 7.4) using the manufacturer's protocol and standard drug concentrations (oligomycin 2 µM, FCCP 2 µM, rotenone 0.5 µM, and antimycin A 0.5 µM).
